Literature DB >> 26592170

Incorporation of cyclic azobenzene into oligodeoxynucleotides for the photo-regulation of DNA hybridization.

Fatma Eljabu1, Joshi Dhruval1, Hongbin Yan2.   

Abstract

Cyclic azobenzene carboxylic acid was synthesized using a shortened route. After reaction with D-threolinol, the resulting cyclic azobenzene-D-threolinol (cAB-Thr) building block was transformed into the corresponding DMTr-protected phosphoramidite, and incorporated into oligodeoxynucleotides at various positions and frequencies by solid phase synthesis. The melting temperatures of these modified oligonucleotides were determined by UV spectrometry. Photo-regulation of cAB-Thr-modified oligonucleotides with their complementary sequence was evaluated by Fluorescence Resonance Energy Transfer experiments using a fluorescein-Black Hole Quencher pair. Results suggest that while cis-cAB destabilizes DNA duplexes, trans-cAB can be accommodated in double stranded DNA.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cyclic azobenzene; FRET; Hybridization; Photoisomerization; Spatiotemporal control

Mesh:

Substances:

Year:  2015        PMID: 26592170     DOI: 10.1016/j.bmcl.2015.10.043

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Locked-Azobenzene: Testing the Scope of a Unique Photoswitchable Scaffold for Cell Physiology.

Authors:  Ek Raj Thapaliya; Jun Zhao; Graham C R Ellis-Davies
Journal:  ACS Chem Neurosci       Date:  2019-02-15       Impact factor: 4.418

2.  Substituted Dibenzodiazocines: Rapid Synthesis and Photochemical Properties.

Authors:  Felix Klockmann; Camilla Fangmann; Elena Zender; Tobias Schanz; Claudia Catapano; Andreas Terfort
Journal:  ACS Omega       Date:  2021-07-08

3.  Photoswitchable Azo- and Diazocine-Functionalized Derivatives of the VEGFR-2 Inhibitor Axitinib.

Authors:  Linda Heintze; Dorian Schmidt; Theo Rodat; Lydia Witt; Julia Ewert; Malte Kriegs; Rainer Herges; Christian Peifer
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.